Temasek invests $250m in China healthcare venture
Singapore's Temasek Holdings has committed $250 million to hospital operator Columbia Pacific Management for a joint venture in China.
Temasek's investment will make it a 50-50 partner with Columbia in Columbia China, its already-established local healthcare arm. Columbia China operates a 220-bed orthopedic hospital, two multi-specialty clinics and three assisted living homes, all in Shanghai and Beijing. Three more multi-specialty hospitals are under development representing a total of up to 1,500 beds, along with another assisted living home in Ningbo and other facilities across China.
The chain will use the capital from Temasek to expand further through acquisitions and greenfield construction, according to a release. It is focusing on large cities where it can address the medical needs of China's expanding middle class.
Seattle-based Columbia Pacific has been active in Asia since 1996, when it opened its first hospital in Malaysia. It now operates 27 hospitals and two clinics across India, Indonesia, Malaysia and Vietnam through its subsidiary Columbia Asia, which received a $101 million investment earlier this year from Japan's Mitsui & Co.
Columbia entered China in 2011, when it gained permission from the Chinese government to build its senior care facilities in Beijing and Shanghai. It later acquired its Shanghai-based hospital and clinic assets.
China's rapidly growing elderly population and their medical needs are putting increasing pressure on the country's healthcare system. According to a report by Deloitte, the number of hospitals in China grew from 20,000 to 24,000 between 2008 and 2014, while private hospitals' share of that total increased from 27% to 47%.
While public hospitals still provide the vast majority of medical services in the country, the government has begun to encourage the use of private hospitals to reduce the burden on public facilities and in 2014 permitted 100% foreign direct ownership of hospitals in several major cities.
These changes have led to a surge of PE interest in China's hospital and healthcare services space in recent years, with AVCJ Research showing $1.4 billion invested in 2014, after less than $500 million total invested between 2005 and 2013.
The pace slowed somewhat since, with $379 million recorded in 2015 and $178 million so far in 2016, but there have still been some significant investments this year. In March, Bain Capital bought a majority stake in hospital operator Asia Pacific Medical Group for $150 million, and CITIC Private Equity invested in cancer hospital business New Journey Hospital Group. Then in May Warburg Pincus committed an undisclosed amount to Shanghai-based hospital chain UIB.
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.








